Advertisement

Pharmaceutical & Diagnostic Innovation

, Volume 2, Issue 5, pp 8–9 | Cite as

Tide Turning Towards Compulsory Trial Registration

Special Report

It is well known by the medical and scientific community that negative clinical trial results are under-reported. Because the practice of selective reporting has far-reaching consequences in terms of publication bias and even medical practice, a call for transparency with respect to the way clinical trials are performed and reported has been made. Such transparency, it is thought, will be achieved through the compulsory registration of all clinical trials in a public database.

Trial registers, be they government-, collaborative- or industry-based projects, have been in existence for at least 40 years. Although the concept is not a new one, there is currently no comprehensive system that organizes, tracks and disseminates information pertaining to ongoing clinical trials in the US.

Recent developments

The idea of a clinical trial registry providing both positive and negative results recently gained momentum following a legal settlement between GlaxoSmithKline(GSK) and the state of New...

Keywords

Publication Bias Clinical Trial Registry Clinical Trial Result Clinical Trial Registration Paxil 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    JAMA (2004); 292 (11): 1363–1364Google Scholar
  2. 2.
    Scrip (2004); 2934: 17Google Scholar

Copyright information

© Adis Data Information BV 2004

Personalised recommendations